Address correspondence to Dr Gregory S. Day, Charles F. and Joanne Knight Alzheimer Disease Research Center, Washington University School of Medicine, 4488 Forest Park Ave, Ste 160, St Louis, MO 63108, gday@wustl.edu.
RELATIONSHIP DISCLOSURE: Dr Day has served as a topic editor on dementia for DynaMed Plus (EBSCO Industries, Inc) and as clinical director for the Anti-NMDA Receptor Encephalitis Foundation. Dr Day receives research/grant support from Avid Radiopharmaceuticals, the Foundation for Barnes Jewish Hospital, and the National Institutes of Health (P01AG03991, R56AG057195) and holds stock in ANI Pharmaceuticals, Inc. Dr Day has provided record review and expert medical testimony on legal cases pertaining to management of Wernicke encephalopathy.
UNLABELED USE OF PRODUCTS/INVESTIGATIONAL USE DISCLOSURE: Dr Day reports no disclosure.